On April 30, 2020, the Food and Drug Administration (FDA) issued new guidance relaxing certain requirements under the Drug Supply Chain Security Act (DSCSA) for COVID-19 related drug products.  In the guidance, FDA explained that under the DSCSA... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences | Pharmacy Law | Physician Dispensing | Specialty Pharmacies

As we reported here, attorneys representing state and local governments in the opioid litigation issued subpoenas to pharmacies that purchased narcotics from certain wholesalers and distributors.  Notably concerning, the same attorneys are now... Read More
Blogs & Articles | Pain Management Compliance | Pharmacy Law | Physician Dispensing

As New Jersey has become a hotspot in the COVID-19 outbreak, physicians and the public-at-large are looking for any remedies that may help alleviate symptoms or assist recovery.  One hot topic has been the use of hydroxychloroquine.  Originally an... Read More
Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Healthcare Law | Life Sciences | Pain Management Compliance | Physician Dispensing | Specialty Pharmacies

https://youtu.be/72DTaqR4_yY Learn more about what Healthcare Providers and Pharmacies should know when it comes to downturns in business from COVID-19 in our latest video with Co-Founder Jonathan Levitt, Esq. and Partner Jesse Dresser,... Read More
Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Employment Matters | Life Sciences | Physician Dispensing | Videos

Major retail pharmacy chains such as CVS and Walgreens have officially pointed the finger at physicians in the multi-district federal opioid litigation by filing third-party complaints against physicians earlier this year. The chains claim that the... Read More
Community, Retail Pharmacies | Healthcare Law | Healthcare Litigation | Life Sciences | Physician Dispensing

Value Based Care is the future of the United States healthcare system and the Office of the Inspector General (OIG) for the US Department of Health and Human Services is in full agreement. The OIG recently issued a Notice of Proposed Rulemaking that... Read More
Life Sciences | Pharmaceutical Wholesalers | Pharmacy Law | Physician Dispensing | Value Based Care

A White Paper by Frier Levitt examines the ongoing practice by Pharmacy Benefit Managers (PBMs) to increase corporate profits through murky "Direct and Indirect Remuneration" fees—commonly known as "DIR Fees"—charged to community oncology... Read More
Blogs & Articles | Defending Pharmacies in PBM Audits | DIR Fees | Pharmacy Law | Physician Dispensing